Guy Chouinard a, b Virginie-Anne Chouinard c aClinical Pharmacology and Toxicology
Program, Departments of Psychiatry and Medicine, McGill University, and bUniversity Mental …

Background: Selective serotonin reuptake inhibitors (SSRI) are widely used in medical
practice. They have been associated with a broad range of symptoms, whose clinical …

Attempts to define selective serotonin reuptake inhibitor (SSRI) withdrawal with the term
'discontinuation syndrome'are not supported by evidence. Acknowledging that SSRI use can …

Adverse events following discontinuation from serotonin reuptake inhibitors (SRIs) are being
reportedin the literature with increasing frequency; the frequency and severity of these …

We studied reported withdrawal symptoms in a retrospective chart review of 352 patients
treated in an outpatient clinic with the nonselective serotonin reuptake inhibitor …

Background: Serotonin-noradrenaline reuptake inhibitors (SNRI) are widely used in medical
practice. Their discontinuation has been associated with a wide range of symptoms. The aim …

Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed in the treatment of
depression and anxiety, as well as obsessive-compulsive, eating, and impulse-control …

Objective Tapering of selective serotonin reuptake inhibitor (SSRI) therapy, as opposed to
abrupt discontinuation, has been recommended by several guidelines and in the literature in …

Recently, Schifano et al.[1] analyzed online self-reporting of misuse of pregabalin, and found
psychedelic dissociative effects induced by pregabalin in this selected population of drug …

Data on discontinuation phenomena associated with serotonin selective reuptake inhibitors
(SSRIs) are derived primarily from (1) published case reports,(2) data bases of adverse drug …